Semagloutide: Kev ua si-hloov pauv ntawm hom 2 qhov kev kho mob ntshav qab zib

Jan 06, 2025

Tso lus

Semaglutide, raws li kev ua yeeb yam ntev-zoo li peptide {2}} ra} ra), tau pom tias muaj kev nyab xeeb thiab kev nyab xeeb hauv kev kho mob ntshav qab zib hom 2. Nws txo qis cov ntshav cov ntshav qab zib ntau dua, suav nrog kev tso pa insulin tso tawm, inhibiting glucagic zais cia, thiab ncua plab nchuav. Tsis tas li ntawd, Semaglutide muaj cov teebmeem kev tiv thaiv tseem ceeb ntawm cov teebmeem, txo txoj kev pheej hmoo ntawm cov xwm txheej plawv. Cov kev tshawb fawb tau qhia tias semaglutide tuaj yeem ua rau theem HBA1c qis dua thiab txo tus neeg mob hnyav. Nrog qhov xwm txheej qis ntawm hypoglycemia thiab cov kev mob tshwm sim ntawm ob peb, nws tau dhau los ua kev xaiv zoo tshaj plaws rau kev kho cov ntshav ntshav qab zib hom 2. Txoj kev tshawb fawb no rov qab saib cov kev tshawb fawb txog semaglutide hauv kev kho mob ntshav qab zib hom 2, suav nrog kev siv hluav taws xob hom, thiab kev nyab xeeb rau kev siv lub cev.

info-1-1

Genohope Biotech Ltd.
Ib tug ua chaw tsim khoom ntawm GLP -1 api
Tus neeg muag khoom los ntawm FDA
Txais tos ib qho kev nug
WhatsApp / Tel: {+8613833133635
Email:info@genohopebio.com

Xa kev nug